Synergism of BARF1 with ras induces malignant transformation in primary primate epithelial cells and human nasopharyngeal epithelial cells

Neoplasia

Volumn 11, Issue 9, 2009, Pages 964-973

  Jiang, Richeng ^a,b,c   Cabras, Giulia ^b   Sheng, Wang ^b   Zeng, Yixin ^c   Ooka, Tadamasa ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITÉ LYON 1   (France)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BAMH I A RIGHT FRAME 1; ONCOPROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; EPITHELIUM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; NASOPHARYNX; NONHUMAN; NOSE MUCOSA; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BALB 3T3 CELLS; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; DRUG SYNERGISM; EPITHELIUM; EPSTEIN-BARR VIRUS INFECTIONS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HERPESVIRUS 4, HUMAN; HUMANS; KIDNEY; MICE; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NIH 3T3 CELLS; PRIMATES; RAS PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TELOMERASE; TRANSFECTION; VIRAL PROTEINS;

EID: 69249105937     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.09706     Document Type: Article

References (59)

1. Young LS and Rickinson AB (2004). Epstein-Barr virus: 40 years on. Nat Rev Cancer 4, 757-768.
2. Young LS and Murray PG (2003). Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22, 5108-5121.
3. Raab-Traub N (2002). Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 12, 431-441.
4. Takada K and Nanbo A (2001). The role of EBERs in oncogenesis. Semin Cancer Biol 11, 461-467.
5. Wood VH, O'Neil JD, Wei W, Stewart SE, Dawson CW, and Young LS (2007). Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFβ signaling pathways. Oncogene 26, 4135-4147.
6. Eliopoulos AG and Young LS (2001). LMP1 structure and signal transduction. Semin Cancer Biol 11, 435-444.
7. Busson P, McCoy R, Sadler R, Gilligan K, Tursz T, and Raab-Traub N (1992). Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J Virol 66, 3257-3262.
8. Kieff E and Rickinson A (2001). Epstein-Barr virus and its replication. In Field's Virology. DM Knipe and PM Howley (Eds). JB Lippincott, Philadelphia, PA.
9. Lo KW, To KF, and Huang DP (2004). Focus on nasopharyngeal carcinoma. Cancer Cell 5, 423-428.
10. Houali K, Wang X, Shimizu Y, Djennaoui D, Nicholls J, Fiorini S, Bouguermouh A, and Ooka T (2007). A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma. Clin Cancer Res 13, 4993-5000.
11. Wang D, Liebowitz D, and Kieff E (1985). An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43, 831-840.
12. Moorthy RK and Thorley-Lawson DA (1993). All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. J Virol 67, 1638-1646.
13. Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, et al. (1988). Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 42, 329-338.
14. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, and Osato T (1994). Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 91, 9131-9135.
15. Decaussin G, Sbih-Lammali F, de Turenne-Tessier M, Bouguermouh A, and Ooka T (2000). Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies. Cancer Res 60, 5584-5588.
16. zur Hausen A, Brink AA, Craanen ME, Middeldorp JM, Meijer CJ, and van den Brule AJ (2000). Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res 60, 2745-2748.
17. Danve C, Decaussin G, Busson P, and Ooka T (2001). Growth transformation of primary epithelial cells with a NPC-derived Epstein-Barr virus strain. Virology 288, 223-235.
18. Sheng W, Decaussin G, Sumner S, and Ooka T (2001). N-terminal domain of BARF1 gene encoded by Epstein-Barr virus is essential for malignant transformation of rodent fibroblasts and activation of BCL-2. Oncogene 20, 1176-1185.
19. Wei MX and Ooka T (1989). A transforming function of the BARF1 gene encoded by Epstein-Barr virus. Embo J 8, 2897-2903.
20. Sheng W, Decaussin G, Ligout A, Takada K, and Ooka T (2003). Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus. J Virol 77, 3859-3865.
21. Wei MX, Moulin JC, Decaussin G, Berger F, and Ooka T (1994). Expression and tumorigenicity of the Epstein-Barr virus BARF1 gene in human Louckes B-lymphocyte cell line. Cancer Res 54, 1843-1848.
22. Wei MX, de Turenne-Tessier M, Decaussin G, Benet G, and Ooka T (1997). Establishment of a monkey kidney epithelial cell line with the BARF1 open reading frame from Epstein-Barr virus. Oncogene 14, 3073-3081.
23. Tsao SW, Wang X, Liu Y, Cheung YC, Feng H, Zheng Z, Wong N, Yuen PW, Lo AK, Wong YC, et al. (2002). Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large Tand HPV16E6/E7 viral oncogenes. Biochim Biophys Acta 1590, 150-158.
24. Zhang H, Tsao SW, Jin C, Strombeck B, Yuen PW, Kwong YL, and Jin Y (2004). Sequential cytogenetic and molecular cytogenetic characterization of an SV40T-immortalized nasopharyngeal cell line transformed by Epstein-Barr virus latent membrane protein-1 gene. Cancer Genet Cytogenet 150, 144-152.
25. Jiang RC, Qin HD, Zeng MS, Huang W, Feng BJ, Zhang F, Chen HK, Jia WH, Chen LZ, Feng QS, et al. (2006). A functional variant in the transcriptional regulatory region of gene LOC344967 cosegregates with disease phenotype in familial nasopharyngeal carcinoma. Cancer Res 66, 693-700.
26. Srinivasan A, McClellan AJ, Vartikar J, Marks I, Cantalupo P, Li Y, Whyte P, Rundell K, Brodsky JL, and Pipas JM (1997). The amino-terminal transforming region of simian virus 40 large T and small T antigens functions as a J domain. Mol Cell Biol 17, 4761-4773.
27. Shay JW, Wright WE, and Werbin H (1991). Defining the molecular mechanisms of human cell immortalization. Biochim Biophys Acta 1072, 1-7.
28. Stubdal H, Zalvide J, Campbell KS, Schweitzer C, Roberts TM, and DeCaprio JA (1997). Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen. Mol Cell Biol 17, 4979-4990.
29. Counter CM, Hahn WC, Wei W, Caddle SD, Beijersbergen RL, Lansdorp PM, Sedivy JM, and Weinberg RA (1998). Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci USA 95, 14723-14728.
30. Halvorsen TL, Leibowitz G, and Levine F (1999). Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol Cell Biol 19, 1864-1870.
31. Lo KW and Huang DP (2002). Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 12, 451-462.
32. Chang JT, Liao CT, Jung SM, Wang TC, See LC, and Cheng AJ (2000). Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues. Br J Cancer 82, 1946-1951.
33. Sbih-Lammali F, Djennaoui D, Belaoui H, Bouguermouh A, Decaussin G, and Ooka T (1996). Transcriptional expression of Epstein-Barr virus genes and protooncogenes in North African nasopharyngeal carcinoma. J Med Virol 49, 7-14.
34. Lo AK, Liu Y, Wang XH, Huang DP, Yuen PW, Wong YC, and Tsao GS (2003). Alterations of biologic properties and gene expression in nasopharyngeal epithelial cells by the Epstein-Barr virus-encoded latent membrane protein 1. Lab Invest 83, 697-709.
35. Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM, DeCaprio JA, and Weinberg RA (2002). Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 22, 2111-2123.
36. Zerrahn J, Knippschild U, Winkler T, and Deppert W (1993). Independent expression of the transforming amino-terminal domain of SV40 large I antigen from an alternatively spliced third SV40 early mRNA. EMBO J 12, 4739-4746.
37. Chen W and Hahn WC (2003). SV40 early region oncoproteins and human cell transformation. Histol Histopathol 18, 541-550.
38. Hammerschmidt W, Sugden B, and Baichwal VR (1989). The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J Virol 63, 2469-2475.
39. Kaykas A and Sugden B (2000). The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation. Oncogene 19, 1400-1410.
40. Liu Y, Wang X, Lo AK, Wong YC, Cheung AL, and Tsao SW (2002). Latent membrane protein-1 of Epstein-Barr virus inhibits cell growth and induces sensitivity to cisplatin in nasopharyngeal carcinoma cells. J Med Virol 66, 63-69.
41. Claudio PP, Howard CM, Fu Y, Cinti C, Califano L, Micheli P, Mercer EW, Caputi M, and Giordano A (2000). Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma. Cancer Res 60, 8-12.
42. Lo KW, Cheung ST, Leung SF, van Hasselt A, Tsang YS, Mak KF, Chung YF, Woo JK, Lee JC, and Huang DP (1996). Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res 56, 2721-2725.
43. Lu QL, Elia G, Lucas S, and Thomas JA (1993). Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int J Cancer 53, 29-35.
44. Hui AB, Lo KW, Teo PM, To KF, and Huang DP (2002). Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization. Int J Oncol 20, 467-473.
45. Porter MJ, Field JK, Leung SF, Lo D, Lee JC, Spandidos DA, and van Hasselt CA (1994). The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngol 114, 105-109.
46. Fan CS, Wong N, Leung SF, To KF, Lo KW, Lee SW, Mok TS, Johnson PJ, and Huang DP (2000). Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma. Hum Pathol 31, 169-178.
47. Yao KT, Zhang HY, Zhu HC, Wang FX, Li GY, Wen DS, Li YP, Tsai CH, and Glaser R (1990). Establishment and characterization of two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus and derived from nasopharyngeal carcinomas. Int J Cancer 45, 83-89.
48. Glaser R, Zhang HY, Yao KT, Zhu HC, Wang FX, Li GY, Wen DS, and Li YP (1989). Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci USA 86, 9524-9528.
49. Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM, and Lee JC (1999). Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer 83, 121-126.
50. Seto E, Yang L, Middeldorp J, Sheen TS, Chen JY, Fukayama M, Eizuru Y, Ooka T, and Takada K (2005). Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J Med Virol 76, 82-88.
51. Seto E, Ooka T, Middeldorp J, and Takada K (2008). Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity. Cancer Res 68, 1030-1036.
52. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, and Weinberg RA (1999). Creation of human tumour cells with defined genetic elements. Nature 400, 464-468.
53. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, and Weinberg RA (2001). Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15, 50-65.
54. Ahuja D, Saenz-Robles MT, and Pipas JM (2005). SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24, 7729-7745.
55. Bikel I, Montano X, Agha ME, Brown M, McCormack M, Boltax J, and Livingston DM (1987). SV40 small T antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen. Cell 48, 321-330.
56. Arroyo JD and Hahn WC (2005). Involvement of PP2A in viral and cellular transformation. Oncogene 24, 7746-7755.
57. Yu J, Boyapati A, and Rundell K (2001). Critical role for SV40 small-T antigen in human cell transformation. Virology 290, 192-198.
58. Watnick RS, Cheng YN, Rangarajan A, Ince TA, and Weinberg RA (2003). Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell 3, 219-231.
59. Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, Shen Q, O'Hagan R, Pantginis J, Zhou H, et al. (1999). Essential role for oncogenic Ras in tumour maintenance. Nature 400, 468-472.